Correlation Between C4 Therapeutics and Third Harmonic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Third Harmonic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Third Harmonic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Third Harmonic Bio, you can compare the effects of market volatilities on C4 Therapeutics and Third Harmonic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Third Harmonic. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Third Harmonic.

Diversification Opportunities for C4 Therapeutics and Third Harmonic

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between CCCC and Third is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Third Harmonic Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Third Harmonic Bio and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Third Harmonic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Third Harmonic Bio has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Third Harmonic go up and down completely randomly.

Pair Corralation between C4 Therapeutics and Third Harmonic

Given the investment horizon of 90 days C4 Therapeutics is expected to under-perform the Third Harmonic. But the stock apears to be less risky and, when comparing its historical volatility, C4 Therapeutics is 1.1 times less risky than Third Harmonic. The stock trades about -0.1 of its potential returns per unit of risk. The Third Harmonic Bio is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  1,379  in Third Harmonic Bio on September 1, 2024 and sell it today you would lose (103.00) from holding Third Harmonic Bio or give up 7.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

C4 Therapeutics  vs.  Third Harmonic Bio

 Performance 
       Timeline  
C4 Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days C4 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Third Harmonic Bio 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Third Harmonic Bio are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Third Harmonic exhibited solid returns over the last few months and may actually be approaching a breakup point.

C4 Therapeutics and Third Harmonic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with C4 Therapeutics and Third Harmonic

The main advantage of trading using opposite C4 Therapeutics and Third Harmonic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Third Harmonic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Third Harmonic will offset losses from the drop in Third Harmonic's long position.
The idea behind C4 Therapeutics and Third Harmonic Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital